Columbia University: Sclerosis trials

The registry lists 14 Sclerosis studies with Columbia University as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 2Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Aspirin for Exercise in Multiple Sclerosis (ASPIRE)CompletedNCT03824938Phase 3Results posted
• Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral SclerosisTerminatedNCT00537446Not applicableResults posted
• Clinical Trial of High Dose CoQ10 in ALSCompletedNCT00243932Phase 2Results posted
• Probiotic Chocolate Study in Multiple SclerosisCompletedNCT06475183Not applicable
• COVID-19 Vaccine Biomarker Study in Multiple SclerosisCompletedNCT05121662
• SUNLIGHT Study: Online Support Groups for MS to Address COVID-19CompletedNCT04379661Not applicable
• Prebiotic vs Probiotic in Multiple SclerosisCompletedNCT04038541Not applicable
• eFIT: An Internet-based Intervention to Increase Physical Activity in Persons With MSCompletedNCT03829267Not applicable
• E-Support Groups in Multiple SclerosisCompletedNCT03574961Not applicable
• Physical Telerehabilitation in Multiple SclerosisCompletedNCT03230903Not applicable
• Genomic Translation for Amyotrophic Lateral Sclerosis CareCompletedNCT02795897
• Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT01363882Not applicable
• Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00537641
• Combination Therapy Selection Trial in Amyotrophic Lateral SclerosisCompletedNCT00355576Phase 2